183 related articles for article (PubMed ID: 25635653)
1. Antibacterial effect of butyryl alkannin from Arnebia euchroma against vancomycin-resistant pathogens of Enterococcus faecalis causing urinary tract infections.
Singh LK; Maheshwari DK; Shukla S
Nat Prod Res; 2015; 29(24):2299-301. PubMed ID: 25635653
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activities of naphthazarins from Arnebia euchroma.
Shen CC; Syu WJ; Li SY; Lin CH; Lee GH; Sun CM
J Nat Prod; 2002 Dec; 65(12):1857-62. PubMed ID: 12502328
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.
Sakagami Y; Kajimura K; Wijesinghe WM; Dharmaratne HR
Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
6. Influence of a subinhibitory concentration of vancomycin on the in vitro expression of virulence-related genes in the vancomycin-resistant Enterococcus faecalis.
Moura TM; Campos FS; Caierão J; Franco AC; Roehe PM; d'Azevedo PA; Frazzon J; Frazzon AP
Rev Soc Bras Med Trop; 2015; 48(5):617-21. PubMed ID: 26516976
[TBL] [Abstract][Full Text] [Related]
7. Compounds from Arnebia euchroma and their related anti-HCV and antibacterial activities.
Li HM; Tang YL; Zhang ZH; Liu CJ; Li HZ; Li RT; Xia XS
Planta Med; 2012 Jan; 78(1):39-45. PubMed ID: 21984340
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of isoprenoid-substituted xanthones from Cudrania cochinchinensis against vancomycin-resistant enterococci.
Fukai T; Oku Y; Hou AJ; Yonekawa M; Terada S
Phytomedicine; 2005 Jun; 12(6-7):510-3. PubMed ID: 16008130
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial and cytotoxic isohexenylnaphthazarins from Arnebia euchroma (Royle) Jonst. (Boraginaceae) callus and cell suspension culture.
Damianakos H; Kretschmer N; Sykłowska-Baranek K; Pietrosiuk A; Bauer R; Chinou I
Molecules; 2012 Dec; 17(12):14310-22. PubMed ID: 23208466
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial infection caused by vancomycin-susceptible multidrug-resistant Enterococcus faecalis over a long period in a university hospital in Japan.
Kudo M; Nomura T; Yomoda S; Tanimoto K; Tomita H
Microbiol Immunol; 2014 Nov; 58(11):607-14. PubMed ID: 25145983
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
[TBL] [Abstract][Full Text] [Related]
14. Wound-healing activity of an oligomer of alkannin/shikonin, isolated from root bark of Onosma echioides.
Nikita G; Vivek P; Chhaya G
Nat Prod Res; 2015; 29(16):1584-8. PubMed ID: 25572039
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of Australian plant extracts against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
Palombo EA; Semple SJ
J Basic Microbiol; 2002; 42(6):444-8. PubMed ID: 12442307
[TBL] [Abstract][Full Text] [Related]
16. A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis.
Qiu XQ; Zhang J; Wang H; Wu GY
Antimicrob Agents Chemother; 2005 Mar; 49(3):1184-9. PubMed ID: 15728923
[TBL] [Abstract][Full Text] [Related]
17. [Study of marine actinomycetes isolated from the central coast of Peru and their antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis].
León J; Aponte JJ; Rojas R; Cuadra D; Ayala N; Tomás G; Guerrero M
Rev Peru Med Exp Salud Publica; 2011 Jun; 28(2):237-46. PubMed ID: 21845303
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial and antiviral naphthazarins from Maharanga bicolor.
Rajbhandari M; Schoepke TH; Mentel R; Lindequist U
Pharmazie; 2007 Aug; 62(8):633-5. PubMed ID: 17867562
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Sader HS; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
[TBL] [Abstract][Full Text] [Related]
20. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
